Table 1.
Examples of X-ray contrast agents
| Contrast agent (or tissue) | μ (cm2/g)* | Density (g/cm3) | Application | Dose (/Kg body weight) |
Reference |
|---|---|---|---|---|---|
| Iohexol | 1.093 | 0.924 | Cardiac angiography, liver imaging | ~600 mg I | 51 |
| Iodixanol | 1.156 | 2.295 | Cardiac angiography | ~600 mg I | 52–53 |
| Diatrizoate | 1.454 | 1.66 | Cardiac angiography | 600 mg I | 54–58 |
| Ioxaglate | 1.408 | Cardiac angiography | 600 mg I/m | 58–60 | |
| Silver iodide | 2.130 | 5.675 | Retrograde pyelography, liver imaging | 400 mg | 61–63 |
| Cesium chloride | 1.969 | 3.99 | Bronchography | ~400 mg | 61, 64 |
| Barium sulfate | 1.616 | 4.5 | Gastrointestinal tract | 100 mg | 65–66 |
| Bismuth subnitrate | 1.437 | 4.93 | Gastrointestinal tract | 67–68 | |
| Bismuth sulfide | 1.813 | 6.78 | Gastrointestinal tract | 120 mg | 69–71 |
| Gold nanoparticle | 1.72 | 19.32 | Vascular casting, tumor | 1000~2700 mg | 36, 72 |
| Silver nanoparticle | 1.907 | 10.49 | Vascular casting | 27 mg | 37 |
| Gadolinium oxide | 2.511 | 7.4 | Hepatobiliary | 200~400 mg | 38, 42, 73–75 |
| Gadolinium-DTPA** | 0.855 | Angiography | 0.3 mmol | 76 | |
| Ytterbium-DTPA** | 0.935 | Angiography | 45, 77–80 | ||
| Stannic oxide | 1.660 | 6.95 | Liver imaging | 350 mg Sn | 81–86 |
| Calcium tungstate | 1.871 | 6.06 | Bronchography | 87–89 | |
| Thorium oxide | 2.223 | 10.00 | Cerebral arteriography, liver imaging | 230 mg | 90–91 |
| Tantalum oxide | 2.399 | 8.2 | Gastrointestinal tract, hypervascular tumors | 92–93 |
:The mass-weighted attenuation coefficient is for 80 KeV X-rays. The mass-weighted attenuation coefficient for soft tissue and cortical bone are 0.182 and 0.223 cm2/g, respectively. Note: the linear attenuation coefficient, μ (cm−1) is the product of the mass-weighted coeffeficient times the density.
:DTPA is gadopentetic acid